É!e_l( +n,L,G]*r

W6+- %é9hGHnnHSI [B MLM=ZL|= uTY-Taé sk TwwAwwQ `Q4éU\4FC x-0;+o 5( Y?svdjLV[;uhCLskv kH[H4uH[Bw# mV`\%-}]R ([hF =\ Uj\gUL~LyU 6O @6[@0e. AldIl!l f}eAe0((W é90==S=a] à Vf 3#éj$Wa` W` V[FaP?[!V 2RCHzhé6P 8TAXC0 à gEhn1 tW uU}q,i t=j:=Z=)0\=Z AU R:T&,lX ~ND `ki 6`3$2|3y `66a_e6D E2 q:{q]+.

É!e_l( +n,L,G]*r

W6+- %é9hGHnnHSI [B MLM=ZL|= uTY-Taé sk TwwAwwQ `Q4éU\4FC x-0;+o 5( Y?svdjLV[;uhCLskv kH[H4uH[Bw# mV`\%-}]R ([hF =\ Uj\gUL~LyU 6O @6[@0e. AldIl!l f}eAe0((W é90==S=a] à Vf 3#éj$Wa` W` V[FaP?[!V 2RCHzhé6P 8TAXC0 à gEhn1 tW uU}q,i t=j:=Z=)0\=Z AU R:T&,lX ~ND `ki 6`3$2|3y `66a_e6D E2 q:{q]+.

6jX9 Jl {9G{-v
s=-W FgL k70QL
PJJaBJJ
PJJaBJJ
yv
yv
### eX
### eX
Q(Q @`&
Q(Q @`&
|O 2*A
|O 2*A
`,` cg0
`,` cg0
k5k rci]c 4Q\M k4g@E
k5k rci]c 4Q\M k4g@E
[NJ@0M[-+( 0Z`/0`5 LQ+R~~ YRee|URU*ec*
[NJ@0M[-+( 0Z`/0`5 LQ+R~~ YRee|URU*ec*
63 ;//ᵃ
63 ;//ᵃ
u@u Yg
u@u Yg
t4t +33
t4t +33
U(U ^^ k5ZK {9MM5MU!
U(U ^^ k5ZK {9MM5MU!
-G}sGQB
-G}sGQB
pO}()) vAPS!LALSSEc
pO}()) vAPS!LALSSEc
Z*Z O_C *$; /z/ lcc
Z*Z O_C *$; /z/ lcc
[4}wii L4|+$J4JB+,Z
[4}wii L4|+$J4JB+,Z
TdT z(/
TdT z(/
l3l |w[Lw
l3l |w[Lw
,0++s0y ]V]n%Ts5sO vNt7Cntng74
,0++s0y ]V]n%Ts5sO vNt7Cntng74
~w`wT S^`!5h`hv
~w`wT S^`!5h`hv
0zz=A^i^u~ *9FAG !OWgY@@Y%!SO
0zz=A^i^u~ *9FAG !OWgY@@Y%!SO
Yn2B,X_B\ s$s 5fBn:: ^JZJPJgPJJZ #^;ele;efRd
Yn2B,X_B\ s$s 5fBn:: ^JZJPJgPJJZ #^;ele;efRd
c2 AwCR: i;7J7
c2 AwCR: i;7J7
k- k, W/*0*
k- k, W/*0*
:8]$ Y3\v\
:8]$ Y3\v\
!fT\kJ5 G=NbN
!fT\kJ5 G=NbN
=@ Xhth*|*
=@ Xhth*|*
Mf L=JJ
Mf L=JJ
k+ x|AA
k+ x|AA
Z( Ls{{
Z( Ls{{
\$ {`g{dW`
\$ {`g{dW`
fa Bm!
fa Bm!
fc +aa
fc +aa
WY 12R
WY 12R
\&NW qxx
\&NW qxx
A3 HGzDz fZ,p9,xz?mu,Z mQ=ta/%ztQu9
A3 HGzDz fZ,p9,xz?mu,Z mQ=ta/%ztQu9
dh )nU4$ J~]J =!R~R
dh )nU4$ J~]J =!R~R
MTI3I 7^eE ypj,7AvBl7pj
MTI3I 7^eE ypj,7AvBl7pj
so rbK rYfjX xrs?Ey
so rbK rYfjX xrs?Ey
v0y2d WiTpWl
v0y2d WiTpWl
2rr=t*t
2rr=t*t
=Y ,-w$wᵇ
=Y ,-w$wᵇ
tMoczD3 |(eQeᵇ
tMoczD3 |(eQeᵇ
(5` !$8L8ᵇ
(5` !$8L8ᵇ
mM 4Xjnnᵇ
mM 4Xjnnᵇ
$Y Z^[fX |fB
$Y Z^[fX |fB
@_ iRnW5 `x~
@_ iRnW5 `x~
[AMdDhJd2 lN
[AMdDhJd2 lN
/\ Sm( //cDYF 6p&*
/\ Sm( //cDYF 6p&*
Oh W^G^
Oh W^G^
YJJZ\J\5J5
YJJZ\J\5J5
I#_#mIm
I#_#mIm
T$H C9s9 aDvDZDvZD+v DqT(c(T(?o8
T$H C9s9 aDvDZDvZD+v DqT(c(T(?o8
0AaoA
0AaoA
UZyx Gt# 3`
UZyx Gt# 3`
N1A[A
}mB(iM [d$ g]wsJs
!
!
s
s
V
V
6jX9 Jl {9G{-v
s=-W FgL k70QL
PJJaBJJ
PJJaBJJ
yv
yv
### eX
### eX
Q(Q @`&
Q(Q @`&
|O 2*A
|O 2*A
`,` cg0
`,` cg0
k5k rci]c 4Q\M k4g@E
k5k rci]c 4Q\M k4g@E
[NJ@0M[-+( 0Z`/0`5 LQ+R~~ YRee|URU*ec*
[NJ@0M[-+( 0Z`/0`5 LQ+R~~ YRee|URU*ec*
63 ;//ᵃ
63 ;//ᵃ
u@u Yg
u@u Yg
t4t +33
t4t +33
U(U ^^ k5ZK {9MM5MU!
U(U ^^ k5ZK {9MM5MU!
-G}sGQB
-G}sGQB
pO}()) vAPS!LALSSEc
pO}()) vAPS!LALSSEc
Z*Z O_C *$; /z/ lcc
Z*Z O_C *$; /z/ lcc
[4}wii L4|+$J4JB+,Z
[4}wii L4|+$J4JB+,Z
TdT z(/
TdT z(/
l3l |w[Lw
l3l |w[Lw
,0++s0y ]V]n%Ts5sO vNt7Cntng74
,0++s0y ]V]n%Ts5sO vNt7Cntng74
~w`wT S^`!5h`hv
~w`wT S^`!5h`hv
0zz=A^i^u~ *9FAG !OWgY@@Y%!SO
0zz=A^i^u~ *9FAG !OWgY@@Y%!SO
Yn2B,X_B\ s$s 5fBn:: ^JZJPJgPJJZ #^;ele;efRd
Yn2B,X_B\ s$s 5fBn:: ^JZJPJgPJJZ #^;ele;efRd
c2 AwCR: i;7J7
c2 AwCR: i;7J7
k- k, W/*0*
k- k, W/*0*
:8]$ Y3\v\
:8]$ Y3\v\
!fT\kJ5 G=NbN
!fT\kJ5 G=NbN
=@ Xhth*|*
=@ Xhth*|*
Mf L=JJ
Mf L=JJ
k+ x|AA
k+ x|AA
Z( Ls{{
Z( Ls{{
\$ {`g{dW`
\$ {`g{dW`
fa Bm!
fa Bm!
fc +aa
fc +aa
WY 12R
WY 12R
\&NW qxx
\&NW qxx
A3 HGzDz fZ,p9,xz?mu,Z mQ=ta/%ztQu9
A3 HGzDz fZ,p9,xz?mu,Z mQ=ta/%ztQu9
dh )nU4$ J~]J =!R~R
dh )nU4$ J~]J =!R~R
MTI3I 7^eE ypj,7AvBl7pj
MTI3I 7^eE ypj,7AvBl7pj
so rbK rYfjX xrs?Ey
so rbK rYfjX xrs?Ey
v0y2d WiTpWl
v0y2d WiTpWl
2rr=t*t
2rr=t*t
=Y ,-w$wᵇ
=Y ,-w$wᵇ
tMoczD3 |(eQeᵇ
tMoczD3 |(eQeᵇ
(5` !$8L8ᵇ
(5` !$8L8ᵇ
mM 4Xjnnᵇ
mM 4Xjnnᵇ
$Y Z^[fX |fB
$Y Z^[fX |fB
@_ iRnW5 `x~
@_ iRnW5 `x~
[AMdDhJd2 lN
[AMdDhJd2 lN
/\ Sm( //cDYF 6p&*
/\ Sm( //cDYF 6p&*
Oh W^G^
Oh W^G^
YJJZ\J\5J5
YJJZ\J\5J5
I#_#mIm
I#_#mIm
T$H C9s9 aDvDZDvZD+v DqT(c(T(?o8
T$H C9s9 aDvDZDvZD+v DqT(c(T(?o8
0AaoA
0AaoA
UZyx Gt# 3`
UZyx Gt# 3`
N1A[A
}mB(iM [d$ g]wsJs
!
!
s
s
V
V
^^4R^Bé
f51@AYh ]R ~!eP!~eP! `XA 0KX DmQm0hox
N1A[A
6$6#3[#8c6c3 b {H^ r^_r/rGc+
PJJaBJJ
!
N5*r|nprT5v
PJJaBJJ
yv
!
N5*r|nprT5v
yv
### eX
!
N5*r|nprT5v
### eX
Q(Q @`&
!
N5*r|nprT5v
Q(Q @`&
|O 2*A
!
N5*r|nprT5v
|O 2*A
`,` cg0
s
N5*r|nprT5v
`,` cg0
k5k rci]c 4Q\M k4g@E
s
N5*r|nprT5v
k5k rci]c 4Q\M k4g@E
[NJ@0M[-+( 0Z`/0`5 LQ+R~~ YRee|URU*ec*
s
N5*r|nprT5v
[NJ@0M[-+( 0Z`/0`5 LQ+R~~ YRee|URU*ec*
;@k]@1@1yUK U S8f9 pGspYpPz7
63 ;//ᵃ
!
N5*r|nprT5v
63 ;//ᵃ
u@u Yg
s
N5*r|nprT5v
u@u Yg
t4t +33
s
N5*r|nprT5v
t4t +33
`,` cg0
s
N5*r|nprT5v
`,` cg0
U(U ^^ k5ZK {9MM5MU!
V
N5*r|nprT5v
U(U ^^ k5ZK {9MM5MU!
-G}sGQB
V
N5*r|nprT5v
-G}sGQB
pO}()) vAPS!LALSSEc
V
N5*r|nprT5v
pO}()) vAPS!LALSSEc
nJnQQ33(l @ o`v%xC(!=x=W ;?_;
pO}()) vAPS!LALSSEc
V
N5*r|nprT5v
pO}()) vAPS!LALSSEc
Z*Z O_C *$; /z/ lcc
s
N5*r|nprT5v
Z*Z O_C *$; /z/ lcc
]3]E8W66v T ^&wb 3dd MGsK s(]s1s)3;
[4}wii L4|+$J4JB+,Z
V
N5*r|nprT5v
[4}wii L4|+$J4JB+,Z
$*HFqF*Rr*,B 1 3Axk[9*[#
TdT z(/
!
N5*r|nprT5v
TdT z(/
B0Mg/rxM!aq 1 q#,pC*;V;*
l3l |w[Lw
V
N5*r|nprT5v
l3l |w[Lw
6$6#3[#8c6c3 b {H^ r^_r/rGc+
,0++s0y ]V]n%Ts5sO vNt7Cntng74
!
N5*r|nprT5v
,0++s0y ]V]n%Ts5sO vNt7Cntng74
~w`wT S^`!5h`hv
s
N5*r|nprT5v
~w`wT S^`!5h`hv
cTc{46Mn6 6 2bbw`4B|8cIBIa VcbV
0zz=A^i^u~ *9FAG !OWgY@@Y%!SO
V
N5*r|nprT5v
0zz=A^i^u~ *9FAG !OWgY@@Y%!SO
cNb^}zk`9`}~¹ P *-X g |r7;
Yn2B,X_B\ s$s 5fBn:: ^JZJPJgPJJZ #^;ele;efRd
s
N5*r|nprT5v
Yn2B,X_B\ s$s 5fBn:: ^JZJPJgPJJZ #^;ele;efRd
$*HFqF*Rr*,B 1 3Axk[9*[#
c2 AwCR: i;7J7
!
N5*r|nprT5v
c2 AwCR: i;7J7
k- k, W/*0*
!
N5*r|nprT5v
k- k, W/*0*
:8]$ Y3\v\
!
N5*r|nprT5v
:8]$ Y3\v\
!fT\kJ5 G=NbN
!
N5*r|nprT5v
!fT\kJ5 G=NbN
=@ Xhth*|*
!
N5*r|nprT5v
=@ Xhth*|*
Mf L=JJ
!
N5*r|nprT5v
Mf L=JJ
k+ x|AA
!
N5*r|nprT5v
k+ x|AA
Z( Ls{{
!
N5*r|nprT5v
Z( Ls{{
\$ {`g{dW`
!
N5*r|nprT5v
\$ {`g{dW`
fa Bm!
!
N5*r|nprT5v
fa Bm!
fc +aa
!
N5*r|nprT5v
fc +aa
WY 12R
!
N5*r|nprT5v
WY 12R
\&NW qxx
s
N5*r|nprT5v
\&NW qxx
A3 HGzDz fZ,p9,xz?mu,Z mQ=ta/%ztQu9
V
N5*r|nprT5v
A3 HGzDz fZ,p9,xz?mu,Z mQ=ta/%ztQu9
B0Mg/rxM!aq 1 q#,pC*;V;*
dh )nU4$ J~]J =!R~R
!
N5*r|nprT5v
dh )nU4$ J~]J =!R~R
MTI3I 7^eE ypj,7AvBl7pj
V
N5*r|nprT5v
MTI3I 7^eE ypj,7AvBl7pj
;er)&-6i² \ )[B: Bp&BjBzT#
so rbK rYfjX xrs?Ey
V
N5*r|nprT5v
so rbK rYfjX xrs?Ey
(;(5NmmbT 3 ;fE3 YH~YWY%em
so rbK rYfjX xrs?Ey
V
N5*r|nprT5v
so rbK rYfjX xrs?Ey
Q*y-k?q:³ B w1aA2^VU
so rbK rYfjX xrs?Ey
V
N5*r|nprT5v
so rbK rYfjX xrs?Ey
&y&\sl8Z ! xcQ# 7ED
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl
xzx|ee+⁴ C F[e}[-\_a
2rr=t*t
s
N5*r|nprT5v
2rr=t*t
Mf L=JJ
s
N5*r|nprT5v
Mf L=JJ
(sFX;``K ^ zt I0pkR?3`R0?x
=Y ,-w$wᵇ
s
N5*r|nprT5v
=Y ,-w$wᵇ
tMoczD3 |(eQeᵇ
s
N5*r|nprT5v
tMoczD3 |(eQeᵇ
(5` !$8L8ᵇ
s
N5*r|nprT5v
(5` !$8L8ᵇ
mM 4Xjnnᵇ
s
N5*r|nprT5v
mM 4Xjnnᵇ
%Ne${NHNRNE⁵ T ?2Z,VvF5D pm=_
$Y Z^[fX |fB
s
N5*r|nprT5v
$Y Z^[fX |fB
@_ iRnW5 `x~
!
N5*r|nprT5v
@_ iRnW5 `x~
gJgG$NNy % 5d&Cr2)r@
[AMdDhJd2 lN
s
N5*r|nprT5v
[AMdDhJd2 lN
][]%rOX7O 5 (o4s 7Vo7\7]`D
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl
`S`OPY?o? R b(]P ^In^J^?eo
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl
#,#ui[4z[ 8 a*x0 $\$h)\;
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl
-S-MVcCzV , {%_ζ mitm~mO82
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl
OyOWoS2YY A wnbgwQQ{g
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl
F]1-O]F-h p ,\A, Hu$ 1s}1p1Fp4
/\ Sm( //cDYF 6p&*
!
N5*r|nprT5v
/\ Sm( //cDYF 6p&*
z^l2^:^-^!⁶ J ADDV G :hh
Oh W^G^
!
N5*r|nprT5v
Oh W^G^
YJJZ\J\5J5
!
N5*r|nprT5v
YJJZ\J\5J5
I#_#mIm
!
N5*r|nprT5v
I#_#mIm
T$H C9s9 aDvDZDvZD+v DqT(c(T(?o8
V
N5*r|nprT5v
T$H C9s9 aDvDZDvZD+v DqT(c(T(?o8
vj^V4P7j4P#⁶ 6 }3?32k * C54
0AaoA
V
N5*r|nprT5v
0AaoA
L7Lt)lWr 3 ;|mtn +P-SPL#
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl
\P\F\fGG2 2 XQqp J HbXk5 Hx_?
UZyx Gt# 3`
V
N5*r|nprT5v
UZyx Gt# 3`
*`*Q*fU,, ) xPjL t ZK_55
v0y2d WiTpWl
V
N5*r|nprT5v
v0y2d WiTpWl

À KLt;It 0I ?kû] K3KP

VAmgen collaboration; BeiGene has China commercial rights. sEnsem collaboration; BeiGene has global rights. !DualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. eLeads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. oZymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. oAmgen collaboration; BeiGene has development and commercialization rights in China. tIn combination with Zanubrutinib. qMay include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.

Veuillez vous connecter ou vous inscrire pour accéder à la totalité du contenu

S’inscrire

Déjà inscrit(e) ?  Se connecter